| Index | — | P/E | 103.53 | EPS (ttm) | 0.36 | Insider Own | — | Shs Outstand | 61.03M | Perf Week | -12.39% |
| Market Cap | 2.27B | Forward P/E | 11.77 | EPS next Y | 3.17 | Insider Trans | -0.65% | Shs Float | 60.13M | Perf Month | -35.05% |
| Enterprise Value | 2.10B | PEG | — | EPS next Q | 0.43 | Short Float | 9.60% | Perf Quarter | -30.72% | ||
| Income | 24.00M | P/S | 3.34 | EPS this Y | 13.05% | Short Ratio | 8.23 | Perf Half Y | -26.82% | ||
| Sales | 682.00M | P/B | 2.52 | EPS next Y | 111.20% | ROA | 1.64% | Short Interest | 5.77M | Perf YTD | 30.41% |
| Book/sh | 14.80 | P/C | 5.30 | EPS next 5Y | — | ROE | 2.62% | 52W High | 86.63 -56.25% | Perf Year | 27.81% |
| Cash/sh | 7.03 | P/FCF | 26.45 | EPS past 3/5Y | -39.84% — | ROIC | 1.89% | 52W Low | 26.00 45.77% | Perf 3Y | 52.50% |
| Dividend Est. | — | EV/EBITDA | 42.91 | Sales past 3/5Y | 0.92% 7.90% | Gross Margin | 37.81% | Volatility | 5.49% 5.28% | Perf 5Y | 65.57% |
| Dividend TTM | — | EV/Sales | 3.08 | EPS Y/Y TTM | -64.44% | Oper. Margin | 3.26% | ATR (14) | 2.92 | Perf 10Y | 75.39% |
| Dividend Ex-Date | — | Quick Ratio | 2.69 | Sales Y/Y TTM | -2.57% | Profit Margin | 3.40% | RSI (14) | 32.39 | Recom | 2.53 |
| Dividend Gr. 3/5Y | — | Current Ratio | 3.93 | EPS Q/Q | -8.33% | SMA20 | -18.27% | Beta | 1.40 | Target Price | 48.33 |
| Payout | 0.00% | Debt/Eq | 0.28 | Sales Q/Q | 16.27% | SMA50 | -18.81% | Rel Volume | 1.51 | Prev Close | 37.27 |
| Employees | 1,265 | LT Debt/Eq | 0.28 | Earnings | Nov 04 | SMA200 | -20.70% | Avg Volume | 705.29K | Price | 37.90 |
| IPO Date | Nov 29, 1994 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 28.02% 7.44% | Net Debt/EBITDA | -3.51 | Volume | 1,062,976 | Change | 1.69% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Oct-14-26 | Reiterated | Oppenheimer | Outperform | $55 → $24 |
| Sep-21-26 | Upgrade | Northland Capital Markets | Market Perform → Outperform | $30 → $66 |
| May-19-26 | Reiterated | Barclays | Equal Weight | $30 → $55 |
| Oct-07-25 | Reiterated | Northland Securities | Outperform | $30 |
| Oct-06-25 | Reiterated | Barclays | Equal Weight | $21 → $30 |
| Oct-03-25 | Downgrade | Needham | Buy → Hold | |
| Jan-06-25 | Upgrade | Citigroup | Neutral → Buy | |
| Jul-15-24 | Downgrade | Citigroup | Buy → Neutral | |
| Jun-27-24 | Reiterated | Oppenheimer | Outperform | $45 → $55 |
| May-15-24 | Reiterated | Oppenheimer | Outperform | $45 |
Veeco Instruments Inc., operating globally with its subsidiaries, specializes in the engineering, production, sale, and support of advanced semiconductor and thin film process equipment used primarily in the manufacture of electronic devices. Their comprehensive product portfolio features systems such as laser annealing, ion beam deposition and etch, metal organic chemical vapor deposition (MOCVD), single wafer wet processing and surface preparation, molecular beam epitaxy (MBE), and atomic layer deposition (ALD), alongside other deposition solutions and packaging lithography tools. These advanced processing platforms are essential for manufacturing diverse microelectronic components, including logic chips, dynamic random-access memory (DRAM), photonics devices, power electronics, radio frequency (RF) filters and amplifiers, magnetic heads for hard disk drives, and various other semiconductor applications. The company's clientele encompasses integrated device manufacturers (IDMs), foundries, outsourced semiconductor assembly and test (OSAT) providers, hard disk drive and photonics producers, as well as educational institutions and research facilities. Established in 1945, Veeco Instruments Inc. is headquartered in Plainview, New York.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 682 | 664 | 717 | 666 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 425 | 399 | 413 | 381 | — | — | — | — | — | |
| Gross Profit | 258 | 265 | 304 | 285 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 74 | 99 | 100 | 93 | — | — | — | — | — | |
| Research and Development | 123 | 120 | 125 | 113 | — | — | — | — | — | |
| Other Operating Expense | 39 | 11 | 12 | 9 | — | — | — | — | — | |
| Operating Income | 23 | 36 | 67 | 70 | — | — | — | — | — | |
| Interest Expense | 8 | 9 | 11 | 12 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 9 | 13 | 13 | -87 | — | — | — | — | — | |
| Net Income Before Taxes | 24 | 39 | 69 | -28 | — | — | — | — | — | |
| Income Taxes | 0 | 4 | -5 | 2 | — | — | — | — | — | |
| Consolidated Net Income | 24 | 35 | 74 | -30 | — | — | — | — | — | |
| Net Income From Continuing Operations | 24 | 35 | 74 | -30 | — | — | — | — | — | |
| Net Income | 24 | 35 | 74 | -30 | — | — | — | — | — | |
| EPS (Recurring) | 0.38 | 0.60 | 1.31 | -0.56 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 0.38 | 0.60 | 1.31 | -0.56 | — | — | — | — | — | |
| EPS (Diluted) | 0.36 | 0.59 | 1.23 | -0.56 | — | — | — | — | — | |
| EBITDA | 49 | 69 | 105 | 8 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 105.28 | 48.44 | 21.79 | — | — | — | — | — | — | |
| Price To Sales Ratio | 3.39 | 2.54 | 2.09 | 2.52 | — | — | — | — | — | |
| Gross Margin | 37.83 | 39.91 | 42.40 | 42.79 | — | — | — | — | — | |
| Operating Margin | 3.37 | 5.42 | 9.34 | 10.51 | — | — | — | — | — | |
| Net Margin | 3.52 | 5.27 | 10.32 | -4.50 | — | — | — | — | — | |
| Shares Outstanding | 61 | 59 | 56 | 54 | — | — | — | — | — | |
| Market Capitalization | 2,312 | 1,686 | 1,501 | 1,676 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Miller William John | CEO | Aug 17 '26 | Sale | 54.18 | 200,000 | 10,836,411 | 169,570 | Aug 19 |
| KIERNAN JOHN P | SVP & CHIEF FINANCIAL OFFICER | Aug 10 '26 | Sale | 51.05 | 35,000 | 1,786,596 | 68,802 | Aug 12 |
| Wilkerson Susan | SVP, GLOBAL SALES & SERVICE | Jun 11 '26 | Sale | 69.56 | 15,506 | 1,078,570 | 27,468 | Jun 12 |
| Devasahayam Adrian | SVP - PRODUCT LINE DEVELOPMENT | Jun 09 '26 | Sale | 65.00 | 10,000 | 650,000 | 85,115 | Jun 10 |
| HUNTER GORDON | Director | Jun 09 '26 | Sale | 68.80 | 16,974 | 1,167,811 | 11,236 | Jun 10 |
| HUNTER GORDON | Director | Jun 04 '26 | Sale | 63.78 | 6,752 | 430,643 | 28,210 | Jun 08 |
| Miller William John | CEO | Jun 02 '26 | Sale | 58.62 | 50,000 | 2,931,000 | 369,570 | Jun 02 |
| HUNTER GORDON | Director | May 26 '26 | Sale | 61.61 | 17,714 | 1,091,360 | 34,962 | May 28 |
| Wilkerson Susan | SVP, GLOBAL SALES & SERVICE | May 26 '26 | Sale | 61.69 | 35,723 | 2,203,752 | 42,974 | May 27 |
| Devasahayam Adrian | SVP - PRODUCT LINE DEVELOPMENT | May 26 '26 | Sale | 61.84 | 5,407 | 334,369 | 95,115 | May 27 |
| DAMORE RICHARD A | Director | May 14 '26 | Sale | 60.71 | 43,701 | 2,653,088 | 112,594 | May 18 |
| HUNTER GORDON | Director | May 12 '26 | Sale | 59.41 | 29,532 | 1,754,496 | 52,676 | May 13 |
| St Dennis Thomas | Director | May 11 '26 | Sale | 61.93 | 1,400 | 86,702 | 61,697 | May 13 |
| HUNTER GORDON | Director | May 08 '26 | Sale | 58.76 | 7,746 | 455,155 | 82,208 | May 11 |
| Miller William John | CEO | May 07 '26 | Sale | 59.55 | 100,000 | 5,955,000 | 419,570 | May 11 |